(Q44661426)

English

Improved ability to perform strenuous activities after treatment with fluticasone propionate/salmeterol combination in patients with persistent asthma

scientific article published in January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Improved ability to perform strenuous activities after treatment with fluticasone propionate/salmeterol combination in patients with persistent asthma (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

based on heuristic

inferred from title

author name string

Robert A Nathan

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Paul Dorinsky

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Jacqueline R Carranza Rosenzweig

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Tushar Shah

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Heather Edin

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Barbara Prillaman

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Journal of Asthma

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

815-822

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

The social impact of asthma

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Effect of inhaled budesonide on bronchial reactivity to histamine, exercise, and eucapnic dry air hyperventilation in patients with asthma

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction.

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA).

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Psychometric performance of the Asthma Quality of Life Questionnaire in a US sample.

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Asthma quality of life during 1 year of treatment with budesonide with or without formoterol.

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Salmeterol/Fluticasone combination inhaler: a new, effective and well tolerated treatment for asthma

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Exercise-induced bronchospasm in children: effects of asthma severity

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Dose-responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Guidelines for the evaluation of impairment/disability in patients with asthma. American Thoracic Society. Medical Section of the American Lung Association

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120023573

21 January 2018

Identifiers

10.1081/JAS-120023573

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

release_r7zhfatfnfb3dof5ci3hzeqnz4

1 reference

https://api.fatcat.wiki/v0/release/r7zhfatfnfb3dof5ci3hzeqnz4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44661426&oldid=2031072169"